FIELD: biotechnology.
SUBSTANCE: invention represents a method for predicting the risk of severe acne, involving selection of patient's whole venous blood, recovering DNA and carrying out molecular-genetic analysis. Molecular genetic analysis of DNA is carried out by high-performance sequencing, and if observing polymorphism of gene MEFV rs104895094, a risk of developing severe acne is predicted.
EFFECT: invention provides more reliable detection of genetic predisposition to severe acne.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING THE RISK OF SEVERE ACNE BASED ON DETERMINING THE EXPRESSION OF IL1RN AND IL10 GENES | 2020 |
|
RU2739890C1 |
| METHOD FOR IDENTIFYING RECESSIVE FACTORS OF GENETIC PREDISPOSITION TO BREAST CANCER | 2013 |
|
RU2535157C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING CHRONIC TRUE ECZEMA IN WOMEN, TAKING INTO ACCOUNT GENETIC FACTORS | 2021 |
|
RU2753274C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING CHRONIC TRUE ECZEMA BASED ON MOLECULAR GENETIC DATA | 2021 |
|
RU2757936C1 |
| METHOD FOR PREDICTING AN INCREASED RISK OF DEVELOPING CHRONIC TRUE ECZEMA IN MEN USING DATA ON FILAGGRIN GENE POLYMORPHISM | 2021 |
|
RU2750963C1 |
| METHOD FOR PREDICTING THE RISK OF SEVERE COVID-19 IN A PATIENT | 2022 |
|
RU2791487C1 |
| DIAGNOSTIC TECHNIQUE FOR THE 167DELT (RS80338942) MUTATION OF THE GJB2 GENE | 2020 |
|
RU2739943C1 |
| METHOD FOR DIAGNOSING THROMBINEMIA IN PATIENTS WITH COVID-19 INFECTION | 2022 |
|
RU2794035C1 |
| DIAGNOSTIC TECHNIQUE OF 35DELG (RS80338939) MUTATION OF GJB2 GENE | 2020 |
|
RU2739889C1 |
| METHOD OF PREDICTION OF ASPIRIN RESISTANCE | 2015 |
|
RU2602664C1 |
